Scleroderma: a general view of the problem

Potekaev N.N.; Korsunskaia I.M.; Guseva S.D.; Nevozinskaia Z.A.

doi:https://doi.org/

Close metadata

Recommended articles:

Cytokine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12

Serum cytokines in patients with brain tumor undergoing uncomplicated and complicated postoperative period. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):21-30

Connective tissue deficiency in the pathogenesis of anterior abdominal wall hernias and modern diagnostic approaches to improve hernioplasty outcomes. Russian Journal of Evidence-Based Gastroenterology. 2025;(3):86-94

Search for informative predictors of the development and progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):124-130

Intraopertive use of local hemostatics in infected wounds. Pirogov Russian Journal of Surgery. 2025;(11):94-100

The influence of polymer additives in the composition of implantable matrices based on collagen and hyaluronic acid on their degradation in vitro. Stomatology. 2025;(6-2):94-99

Using label-free Raman spectroscopy to quantify matrix-associated aging products in tissues of various organs in an animal model. Plastic Surgery and Aesthetic Medicine. 2025;(4):58-62

Molecular diagnostic biomarkers of subretinal fluid in assessing the severity and prognosis of rhegmatogenous retinal detachment. Russian Annals of Ophthalmology. 2025;(6):119-126

Comparative study of structural properties of polymeric matrixes. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(4):47-51

Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects. Russian Bulletin of Obstetrician-Gynecologist. 2026;(1):42-50

Abstract:

The authors analyze the data available in the literature on the etiology and pathogenesis of scleroderma.

Keywords:

scleroderma

collagen

matrix metalloproteinase

Borrelia burgdorferi

interleukins

autoantibodies.

Authors:

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

SPIN RSCI: 8862-5688
Scopus AuthorID: 56437430600
ORCID: 0000-0002-9578-5490

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Guseva S.D.

Dermatovenerological Dispensary #16, Moscow

Nevozinskaia Z.A.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Close metadata

References:

Fitspatrik T., Dzhonson R., Vulf K., Polano M., Syurmond D. Dermatologiya. Atlas-spravochnik. M 1999.
Berenbein B.A., Studnitsyn A.A. Differentsial'naya diagnostika kozhnykh boleznei. Rukovodstvo dlya vrachei. 2-e izd. M: Meditsina 1989.
Babkin A.V. Kliniko-immunologicheskaya kharakteristika pozdnikh kozhnykh proyavlenii iksodovogo kleshchevogo borrelioza v Severo-Zapadnom regione Rossii: Avtoref. dis. … kand. med. nauk. SPb 1998.
Palacios R., Torres A., Trujillo R. IgG antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients with morphea in Colombia. Int J Dermatol 2003; 42: 11: 882-886.
Eisendle K., Grabner T., Zelger B. Morphoea: a manifestation of infection with Borrelia species? Br J Dermatol 2007; 157: 6: 1189-1198.
Hummers L.K. Biomarkers of vascular disease in scleroderma. Rheumatology (Oxford) 2008; 47: Suppl: 5: v21-v22.
Kahaleh B. The microvascular endothelium in scleroderma. Rheumatology (Oxford) 2008; 47: Suppl: 5: v14-v15.
Gomer R.H. Circulating progenitor cells and scleroderma. Curr Rheumatol Rep 2008; 10: 3: 183-188.
El-Mofty M., Mostafa W., El-Darouty M., Bosseila M., Nada H., Yousef R., Esmat S., El-Lawindy M., Assaf M., El-Enani G. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed 2004; 20: 3: 148-156.
Wojas-Pelc A., Lipko-Godlewska S. Pathogenesis of skin scleroderma-literature review. Przegl Lek 2005; 62: 5: 310-313.
Dziankowska-Bartkowiak B., Żebrowska A., Erkiert-Polguj A., Wągrowska-Danilewicz M., Sysa-Jędrzejowska M., Waszczykowska E. Wybrane selektyny i integryny w zmianach skórnych twardziny układowej. Post Dermatol Alergol 2007; 24: 6: 256-262.
Santos S.N., Oliveira G.V., Tavares A.L., Massensini A.R., Carvalhaes L.M., Reljasvaara R., Kitten G.T. Collagen XVIII and fibronectin involvement in bullous scleroderma. Dermatol Online J 2005; 11: 1: 17.
Soldano S., Montagna P., Villaggio B., Parodi A., Gianotti G., Sulli A., Seriolo B., Secchi M.E., Cutolo M. Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts. Ann Rheum Dis 2009; 68: 4: 599-602.
Hemmatazad H., Rodrigues H.M., Maurer B., Brentano F., Pileckyte M., Distler J.H., Gay R.E., Michel B.A., Gay S., Huber L.C., Distler O., Jüngel A. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis Rheum 2009; 60: 5: 1519-1529.
Karrer S., Bosserhoff A.K., Weiderer P., Landthaler M., Szeimies R.M. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004; 151: 4: 776-783.
Hummers L.K., Hall A., Wigley F.M., Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 2009; 36: 3: 576-582.
Asano Y., Ihn H., Kubo M., Jinnin M., Mimura Y., Ashida R., Tamaki K. Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma. Clin Exp Rheumatol 2006; 24: 4: 394-399.
Ferzli G.T., El-Tal Ael-K., Kibbi A.G., Mikati M.A. Localized morphea: a rare adverse effect of valproic acid. Pediatr Neurol 2003; 29: 3: 253-255.
Ho J., Rothchild Y.H., Sengelmann R. Vitamin B12-associated localized scleroderma and its treatment. Dermatol Surg 2004; 30: 9: 1252-1255.
Itoh M., Yanaba K., Kobayashi T., Nakagawa H. Taxane-induced scleroderma. Br J Dermatol 2007; 156: 2: 363-367.
Kikuchi K., Hoashi T., Yazawa N., Tamaki K. Pseudoscleroderma associated with cancer. Clin Exp Dermatol 2006; 31: 3: 381-383.
Dubner S., Bovi J., White J., Susnik B. Postirradiation morphea in a breast cancer patient. Breast J 2006; 12: 2: 173-176.
Androutsopoulos G., Adonakis G., Tsamantas A., Liosis S., Antonopoulos A., Kourounis G. Synchronous primary cancers in a woman with scleroderma: a case report. Eur J Gynaecol Oncol 2008; 29: 5: 548-550.
Nunez S., Konstantinov K.N., Servilla K.S., Hartshorne M.F., Williams W.L., Gibel L.J., Tzamaloukas A.H. Association between scleroderma, renal cell carcinoma and membranous nephropathy. Clin Nephrol 2009; 71: 1: 63-68.
Khamaganova I.V., Dvornikov A.S. Endocrine disturbances in circumscribed Scleroderma. Ter Arkh 2005; 77: 10: 39-44.
Ludwig R.J., Werner R.J., Winker W., Boehncke W.H., Wolter M., Kaufmann R. Chronic venous insufficiency - a potential trigger for localized scleroderma. J Eur Acad Dermatol Venereol 2006; 20: 1: 96-99.
Bonifati C., Impara G., Morrone A., Pietrangeli A., Carducci M. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 1: 63-65.
Chappell J.A., Burkemper N.M., Frater J.L., Hurley M.Y. Cutaneous rosai-dorfman disease and morphea: coincidence or association? Am J Dermatopathol 2009; 31: 5: 487-489.
González-López M.A., Drake M., González-Vela M.C., Armesto S., Llaca H.F., Val-Bernal J.F. Generalized morphea and primary biliary cirrhosis coexisting in a male patient. J Dermatol 2006; 33: 10: 709-713.
Zeglaoui H., Landolsi H., Mankai A., Ghedira I., Bouajina E. Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheumatol Int 2009; 30: 6: 793-795.
Yamamoto M., Yamamoto T., Tsuboi R. Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection. Rheumatol Int 2010; 30: 7: 969-971.
Karrer S., Bosserhoff A.K., Weiderer P., Landthaler M., Szeimies R.M. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004; 151: 4: 776-783.
Kreuter A., Hyun J., Skrygan M., Sommer A., Bastian A., Altmeyer P., Gambichler T. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol 2006; 155: 3: 600-607.
Kawai M., Masuda A., Kuwana M. A CD40-CD154 interaction in tissue fibrosis. Arthritis Rheum 2008; 58: 11: 3562-3573.
Hudson L.L., Rocca K.M., Kuwana M., Pandey J.P. Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses. Genes Immun 2005; 6: 3: 274-278.
Hikami K., Ehara Y., Hasegawa M., Fujimoto M., Matsushita M., Oka T., Takehara K., Sato S., Tokunaga K., Tsuchiya N. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. Biochem Biophys Res Commun 2008; 373: 3: 403-407.
van Lieshout A.W., Vonk M.C., Bredie S.J., Joosten L.B., Netea M.G., van Riel P.L., Lafyatis R., van den Hoogen F.H., Radstake T.R. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009; 38: 4: 282-290.
Matsushita M., Yamamoto T., Yokozeki H. Role of cytokines and proteases in murine scleroderma. J Med Dent Sci 2008; 55: 3-4: 215-225.
Lafyatis R., York M. Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol 2009; 21: 6: 617-622.
Rankin A.L., Mumm J.B., Murphy E., Turner S., Yu N., McClanahan T.K., Bourne P.A., Pierce R.H., Kastelein R., Pflanz S. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010; 184: 3: 1526-1535.
Suzuki J., Morimoto S., Amano H., Tokano Y., Takasaki Y., Hashimoto H. Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 2001; 28: 11: 2389-2391.
Wang H.W., Tedla N., Hunt J.E., Wakefield D., McNeil H.P. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma. Exp Dermatol 2005; 14: 4: 295-302.
Wuttge D.M., Wildt M., Geborek P., Wollheim F.A., Scheja A., Akesson A. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease. Arthritis Res Ther 2007; 9: 5: R85.
Mosaad Y.M., Metwally S.S., Auf F.A., AbdEL-Samee E.R., el-Deek B., Limon N.I., el-Chennawi F.A. Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production. Egypt J Immunol 2003; 10: 2: 19-26.
Meloni F., Caporali R., Marone Bianco A., Paschetto E., Morosini M., Fietta A.M., Patrizio V., Bobbio-Pallavicini F., Pozzi E, Montecucco C. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 2: 111-118.
Kim H.J., Song S.B., Choi J.M., Kim K.M., Cho B.K., Cho D.H., Park H.J. IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. J Invest Dermatol 2010; 130: 3: 706-715.
Nakamura K., Kawakami Y., Oyama N., Kaneko F., Abe H., Sagara H., Ohto H. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation. J Dermatol 2006; 33: 2: 135-138.
Zhou L., Askew D., Wu C., Gilliam A.C. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 2007; 127: 2: 281-292.
Magnant J., de Monte M., Guilmot J.L., Lasfargues G., Diot P., Asquier E., Degenne D., Boissinot E., Diot E. Relationship between occupational risk factors and severity markers of systemic sclerosis. J Rheumatol 2005; 32: 9: 1713-1718.
Volpe A., Ruzzenente O., Caramaschi P., Pieropan S., Tinazzi I., Carletto A., Bambara L.M., Biasi D. Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis. Rheumatol Int 2009; 29: 9: 1073-1079.
Admou B., Essaadouni L., Amal S., Arji N., Chabaa L., El Aouad R. Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach. Ann Biol Clin (Paris) 2009; 67: 3: 273-281.
Mahler M., Fritzler M.J. The changing landscape of the clinical value of the PM/Scl autoantibody system. Arthritis Res Ther 2009; 11: 2: 106.